A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)

Publication | Open Access

DOI Full Paper Access

213

Citations

References

2020

Year

Ivan Titov, Richard G. Wunderink, Antoine Roquilly, Daniel González, Aileen David-Wang, Helen W. Boucher, Keith S. Kaye, Maria C Losada, Jiejun Du, Robert Tipping,

Clinical Infectious Diseases

Abstract

References